In this episode, we’ll take a deeper look into our Newmarker’s Newsmakers with Andrew Jay, general partner at the Borna Health Fund, a hedge fund that invests in medical technology companies. We’ll take about Stryker’s recent regulatory success; Quidel’s game-changing acquisition; Medtronic’s dialysis deal with DaVita and shareholder votes against executive pay at Masimo. We’ll also take a deeper look into the swirling speculation that Johnson & Johnson could look to buy Boston Scientific. In the second half of the show, we’ll run our latest MedtronicTalks podcast episode that highlighted the work the company and industry is doing to identify and combat healthcare inequity. Finally, we’ll also hear some helpful advice on cybersecurity.


#5. https://www.massdevice.com/strykers-spine-guidance-software-fda-clearance/

#4 https://www.massdevice.com/quidel-ortho-clinical-diagnostics-combine/

#3 https://www.massdevice.com/medtronic-davita-kidney-device-company/

#2 https://www.massdevice.com/masimo-no-vote-executive-pay/


#1
https://www.drugdeliverybusiness.com/dexcom-quashes-insulet-merger/
https://www.massdevice.com/will-johnson-johnson-buy-boston-scientific/

Subscribe on any major podcast channel.

Ver todos los episodios